BREAST CANCER: ACMG have issued guidance against testing all patients with breast cancer for inherited predisposition; rather, they favour careful case-by-case assessment of risk

Web

Dec. 23, 2019

SCIENTIFIC

The ACMG position contrasts with recent guidance from the American Society of Breast Surgeons recommending testing of all newly diagnosed breast cancer patients for germline predisposition.

ACMG Statement: https://www.nature.com/articles/s41436-019-0712-x and the official Statement the American Society of Breast Surgeons: https://www.breastsurgeons.org/docs/statements/Consensus-Guideline-on-Genetic-Testing-for-Hereditary-Breast-Cancer.pdf